16 0 2 0 2 B-lower_bound
to 3 5 3 5 O
85 6 8 6 8 B-upper_bound
years 9 14 9 14 I-upper_bound
of 15 17 15 17 O
age 18 21 18 21 B-age

Diagnosis 0 9 22 31 O
of 10 12 32 34 O
DEFINITE 13 21 35 43 O
Myasthenia 22 32 44 54 B-chronic_disease
Gravis 33 39 55 61 I-chronic_disease

Female 0 6 62 68 B-gender
patients 7 15 69 77 I-gender
of 16 18 78 80 O
childbearing 19 31 81 93 O
potential 32 41 94 103 O
who 42 45 104 107 O
are 46 49 108 111 O
not 50 53 112 115 O
be 54 56 116 118 O
breastfeeding 57 70 119 132 O

Female 0 6 133 139 B-gender
subject 7 14 140 147 O
has 15 18 148 151 O
a 19 20 152 153 O
history 21 28 154 161 O
of 29 31 162 164 O
breast 32 38 165 171 B-cancer
cancer 39 45 172 178 I-cancer
screening 46 55 179 188 O
that 56 60 189 193 O
is 61 63 194 196 O
suspicious 64 74 197 207 O
for 75 78 208 211 O
malignancy 79 89 212 222 B-cancer
and 90 93 223 226 O
in 94 96 227 229 O
whom 97 101 230 234 O
the 102 105 235 238 O
possibility 106 117 239 250 O
of 118 120 251 253 O
malignancy 121 131 254 264 O

History 0 7 265 272 O
of 8 10 273 275 O
inadequate 11 21 276 286 O
response 22 30 287 295 O
to 31 33 296 298 O
conventional 34 46 299 311 O
MG 47 49 312 314 B-treatment
treatment 50 59 315 324 I-treatment

Subject 0 7 325 332 O
has 8 11 333 336 O
a 12 13 337 338 O
history 14 21 339 346 O
of 22 24 347 349 O
Chronic 25 32 350 357 B-chronic_disease
Obstructive 33 44 358 369 I-chronic_disease
Pulmonary 45 54 370 379 I-chronic_disease
Disease 55 62 380 387 I-chronic_disease
( 63 64 388 389 I-chronic_disease
COPD 64 68 389 393 I-chronic_disease
) 68 69 393 394 I-chronic_disease

Subject 0 7 395 402 O
has 8 11 403 406 O
a 12 13 407 408 O
history 14 21 409 416 O
of 22 24 417 419 O
cancer 25 31 420 426 B-cancer
in 32 34 427 429 O
the 35 38 430 433 O
last 39 43 434 438 O
5 44 45 439 440 O
years 46 51 441 446 O

Subject 0 7 447 454 O
has 8 11 455 458 O
a 12 13 459 460 O
history 14 21 461 468 O
of 22 24 469 471 O
serious 25 32 472 479 O
bacterial 33 42 480 489 B-chronic_disease
infection 43 52 490 499 I-chronic_disease
within 53 59 500 506 O
in 60 62 507 509 O
the 63 66 510 513 O
last 67 71 514 518 B-upper_bound
3 72 73 519 520 I-upper_bound
months 74 80 521 527 I-upper_bound
, 80 81 527 528 O
unless 82 88 529 535 O
treated 89 96 536 543 O
and 97 100 544 547 O
resolved 101 109 548 556 O
with 110 114 557 561 O
antibiotics 115 126 562 573 B-treatment
; 126 127 573 574 O
or 128 130 575 577 O
, 130 131 577 578 O
any 132 135 579 582 O
chronic 136 143 583 590 O
bacterial 144 153 591 600 O
infection 154 163 601 610 O

Subject 0 7 611 618 O
has 8 11 619 622 O
evidence 12 20 623 631 O
of 21 23 632 634 O
active 24 30 635 641 O
or 31 33 642 644 O
latent 34 40 645 651 O
bacterial 41 50 652 661 O
or 51 53 662 664 O
viral 54 59 665 670 O
infections 60 70 671 681 B-chronic_disease
, 70 71 681 682 O
including 72 81 683 692 O
positive 82 90 693 701 O
infectious 91 101 702 712 O
disease 102 109 713 720 O
laboratory 110 120 721 731 O
test 121 125 732 736 O
result 126 132 737 743 O
( 133 134 744 745 O
Hepatitis 134 143 745 754 B-chronic_disease
B 144 145 755 756 I-chronic_disease
, 145 146 756 757 O
Hepatitis 147 156 758 767 B-chronic_disease
C 157 158 768 769 I-chronic_disease
or 159 161 770 772 O
HIV 162 165 773 776 B-chronic_disease
) 165 166 776 777 O

Subject 0 7 778 785 O
has 8 11 786 789 O
had 12 15 790 793 O
no 16 18 794 796 O
previous 19 27 797 805 O
trial 28 33 806 811 O
of 34 36 812 814 O
other 37 42 815 820 O
immunosuppressive 43 60 821 838 B-treatment
agents 61 67 839 845 I-treatment

Subject 0 7 846 853 O
has 8 11 854 857 O
had 12 15 858 861 O
previous 16 24 862 870 O
exposure 25 33 871 879 O
to 34 36 880 882 O
Orencia 37 44 883 890 B-treatment
( 45 46 891 892 O
abatacept 46 55 892 901 O
) 55 56 901 902 O

Subject 0 7 903 910 O
has 8 11 911 914 O
neurological 12 24 915 927 B-chronic_disease
impairment 25 35 928 938 I-chronic_disease
due 36 39 939 942 O
to 40 42 943 945 O
a 43 44 946 947 O
condition 45 54 948 957 O
other 55 60 958 963 O
than 61 65 964 968 O
MG 66 68 969 971 O
, 68 69 971 972 O
including 70 79 973 982 O
history 80 87 983 990 O
of 88 90 991 993 O
transient 91 100 994 1003 B-chronic_disease
ischemic 101 109 1004 1012 I-chronic_disease
attack 110 116 1013 1019 I-chronic_disease
within 117 123 1020 1026 O
the 124 127 1027 1030 O
past 128 132 1031 1035 O
year 133 137 1036 1040 O

Subject 0 7 1041 1048 O
has 8 11 1049 1052 O
received 12 20 1053 1061 O
any 21 24 1062 1065 O
live 25 29 1066 1070 B-treatment
vaccine 30 37 1071 1078 I-treatment
within 38 44 1079 1085 O
3 45 46 1086 1087 B-upper_bound
months 47 53 1088 1094 I-upper_bound
of 54 56 1095 1097 O
screening 57 66 1098 1107 O

Subject 0 7 1108 1115 O
has 8 11 1116 1119 O
the 12 15 1120 1123 O
presence 16 24 1124 1132 O
at 25 27 1133 1135 O
screening 28 37 1136 1145 O
of 38 40 1146 1148 O
any 41 44 1149 1152 O
severe 45 51 1153 1159 O
, 51 52 1159 1160 O
progressive 53 64 1161 1172 O
or 65 67 1173 1175 O
uncontrolled 68 80 1176 1188 O
renal 81 86 1189 1194 B-chronic_disease
, 86 87 1194 1195 O
hepatic 88 95 1196 1203 B-chronic_disease
, 95 96 1203 1204 O
hematologic 97 108 1205 1216 B-chronic_disease
, 108 109 1216 1217 O
gastrointestinal 110 126 1218 1234 B-chronic_disease
, 126 127 1234 1235 O
pulmonary 128 137 1236 1245 B-chronic_disease
, 137 138 1245 1246 O
cardiac 139 146 1247 1254 B-chronic_disease
, 146 147 1254 1255 O
neurologic 148 158 1256 1266 B-chronic_disease
or 159 161 1267 1269 O
cerebral 162 170 1270 1278 B-chronic_disease
disease 171 178 1279 1286 I-chronic_disease
, 178 179 1286 1287 O
whether 180 187 1288 1295 O
or 188 190 1296 1298 O
not 191 194 1299 1302 O
related 195 202 1303 1310 O
to 203 205 1311 1313 O
MG 206 208 1314 1316 O
that 209 213 1317 1321 O
, 213 214 1321 1322 O
in 215 217 1323 1325 O
the 218 221 1326 1329 O
opinion 222 229 1330 1337 O
of 230 232 1338 1340 O
the 233 236 1341 1344 O
Investigator 237 249 1345 1357 O
, 249 250 1357 1358 O
might 251 256 1359 1364 O
place 257 262 1365 1370 O
the 263 266 1371 1374 O
subject 267 274 1375 1382 O
at 275 277 1383 1385 O
unacceptable 278 290 1386 1398 O
risk 291 295 1399 1403 O
for 296 299 1404 1407 O
participation 300 313 1408 1421 O
in 314 316 1422 1424 O
the 317 320 1425 1428 O
study 321 326 1429 1434 O

Subject 0 7 1435 1442 O
has 8 11 1443 1446 O
undergone 12 21 1447 1456 O
a 22 23 1457 1458 O
change 24 30 1459 1465 O
in 31 33 1466 1468 O
immunosuppressive 34 51 1469 1486 B-treatment
medications 52 63 1487 1498 I-treatment
within 64 70 1499 1505 O
the 71 74 1506 1509 O
last 75 79 1510 1514 B-upper_bound
three 80 85 1515 1520 I-upper_bound
months 86 92 1521 1527 I-upper_bound
prior 93 98 1528 1533 I-upper_bound
to 99 101 1534 1536 O
enrollment 102 112 1537 1547 O

Subject 0 7 1548 1555 O
is 8 10 1556 1558 O
at 11 13 1559 1561 O
risk 14 18 1562 1566 O
for 19 22 1567 1570 O
tuberculosis 23 35 1571 1583 B-chronic_disease

have 0 4 1584 1588 O
a 5 6 1589 1590 O
negative 7 15 1591 1599 B-pregnancy
pregnancy 16 25 1600 1609 I-pregnancy
test 26 30 1610 1614 O

non 0 3 1615 1618 B-cancer
- 3 4 1618 1619 I-cancer
melanoma 4 12 1619 1627 I-cancer
skin 13 17 1628 1632 I-cancer
cell 18 22 1633 1637 I-cancer
cancers 23 30 1638 1645 I-cancer
cured 31 36 1646 1651 O
by 37 39 1652 1654 O
local 40 45 1655 1660 B-treatment
resection 46 55 1661 1670 I-treatment
or 56 58 1671 1673 O
carcinoma 59 68 1674 1683 B-cancer
in 69 71 1684 1686 I-cancer
situ 72 76 1687 1691 I-cancer

